West African Centre for Cell Biology of Infectious Pathogens (WACBIP), Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Accra, Ghana.
Department of Medical Laboratory Sciences, University of Ghana, Accra, Ghana.
Front Public Health. 2024 Oct 1;12:1367586. doi: 10.3389/fpubh.2024.1367586. eCollection 2024.
COVID-19 disruptions including lockdowns and prioritization of COVID-19 control programs in Africa in 2020-2022 contributed to reductions in malaria control activities including malaria diagnosis, treatment and resistance monitoring. This study investigated the malaria burden and distribution on the background of active transmission of SARS-CoV-2 in Southern Ghana; utilizing community health education and medical screening (CHEMS) approach to determine epidemiological overlaps in COVID-19 and malaria.
Between October-December 2022, prospective cross-sectional surveys, with CHEMS were conducted in Greater Accra and Central regions, where 994 participants enrolled either at a hospital or community setting provided demographic and clinical data including history of clinical malaria infection and antimalarial treatment in the past 2 weeks. Of this study population, 953 provided nasal/throat swabs for COVID-19 RT-PCR testing, with a subset of 136 participants also providing finger-prick blood for malaria RDT testing.
The study population comprised of 73.6% adults, with 54.6% COVID-19 vaccination rate. Overall, 18.1% of participants had a history of clinical malaria, which was associated (adjusted odds ratio > 1.50, -value ≤0.022) with COVID-19 symptoms and positivity, study area and hospital setting, suggestive of overlaps in the epidemiological risk for malaria. On a background of widespread SARS-CoV-2 infections (12-37%), malaria parasitaemia was detected in 6%, with 2% being co-infections with SARS-CoV-2. Among the malaria positives, 9.5% had a history of antimalarial treatment, which suggested that their infections were recrudescent parasitaemia.
The epidemiological and clinical overlap between malaria and COVID-19 within the hospital and community settings underscores the need for accurate case diagnosis to inform effective clinical treatments. Innovative surveillance programs, with community engagement are needed to maximize control interventions including treatment of asymptomatic malaria infections.
2020 年至 2022 年,非洲因新冠疫情封锁以及优先控制新冠疫情,导致疟疾控制活动减少,包括疟疾诊断、治疗和耐药性监测。本研究调查了 SARS-CoV-2 在加纳南部活跃传播背景下的疟疾负担和分布情况;利用社区卫生教育和医疗筛查(CHEMS)方法来确定新冠疫情和疟疾的流行病学重叠。
2022 年 10 月至 12 月,在大阿克拉和中部地区进行了前瞻性横断面调查,在医院或社区环境中登记了 994 名参与者,提供了人口统计学和临床数据,包括过去 2 周内临床疟疾感染和抗疟治疗史。在该研究人群中,953 人提供了鼻/咽拭子进行新冠病毒 RT-PCR 检测,其中 136 人还提供了手指刺血进行疟疾 RDT 检测。
研究人群中 73.6%为成年人,54.6%接种过新冠疫苗。总体而言,18.1%的参与者有临床疟疾史,与新冠症状和阳性率(调整后的优势比>1.50,-值≤0.022)、研究区域和医院环境有关,表明疟疾的流行病学风险存在重叠。在广泛的 SARS-CoV-2 感染(12-37%)背景下,检测到 6%的疟疾寄生虫血症,其中 2%为 SARS-CoV-2 合并感染。在疟疾阳性者中,9.5%有抗疟治疗史,表明他们的感染是复发性寄生虫血症。
医院和社区环境中疟疾和新冠疫情的流行病学和临床重叠,突出了准确诊断病例以指导有效临床治疗的必要性。需要通过社区参与的创新监测计划,最大限度地开展控制干预措施,包括治疗无症状疟疾感染。